651 Neurological adverse events associated with immune checkpoint inhibitors: Our experience in a tertiary care center
Main Authors: | Pablo Alvarez-Ballesteros, Javier Buisan-Catevilla, Alvaro Beltrán-Corbellini, Iñigo Corral-Corral, Javier Pozas-Perez, Victor Albarran-Fernandez, Lucia Sanz-Gomez, Jorge Esteban-Villarrubia, Javier Torres-Jimenez, Jesús Chamorro-Perez, Diana Rosero-Rodriguez, María San Román-Gil, Ainara Soria-Rivas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Neurologic Toxicity of Immune Checkpoint Inhibitors: A Review of Literature
by: Víctor Albarrán, et al.
Published: (2022-02-01) -
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
by: María San-Román-Gil, et al.
Published: (2023-01-01) -
Orthogonal impact load in 6061-T651 and 7075-T651 aluminum alloy plates
by: J.A. Frutos, et al.
Published: (2023-09-01) -
Adoptive T cell therapy for solid tumors: current landscape and future challenges
by: Víctor Albarrán, et al.
Published: (2024-03-01) -
Novel Tyrosine Kinase Targets in Urothelial Carcinoma
by: Javier Torres-Jiménez, et al.
Published: (2021-01-01)